Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Albrecht, Helmut
One or more keywords matched the following items that are connected to Albrecht, Helmut
Item TypeName
Concept HIV Integrase Inhibitors
Concept HIV-1
Concept HIV Infections
Concept Anti-HIV Agents
Concept HIV Protease Inhibitors
Concept HIV
Concept HIV Core Protein p24
Academic Article Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients.
Academic Article Epidemiological characterization of individuals with newly reported HIV infection: South Carolina, 2004-2005.
Academic Article CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.
Academic Article Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. When to start HIV treatment in infants.
Academic Article Report from the 15th Retrovirus Conference. Durability of new agents for treatment-experienced patients.
Academic Article Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals.
Academic Article HIV and community-acquired MRSA.
Academic Article Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster.
Academic Article Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis.
Academic Article Missed opportunities for early HIV diagnosis in correctional facilities.
Academic Article Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes.
Academic Article Report from the 17th Conference on Retroviruses and Opportunistic Infections. CCR5 antagonists--out with the old, in with the new?
Academic Article Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner.
Academic Article Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year.
Academic Article HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several "one pill, once-daily" options.
Academic Article Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
Academic Article Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011.
Academic Article Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
Academic Article Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults.
Academic Article Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina.
Academic Article Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases.
Academic Article The South Carolina HIV Cascade of Care.
Academic Article HIV community viral load trends in South Carolina.
Academic Article New HCV treatment paradigms--now also for patients with HIV.
Academic Article The South Carolina rural-urban HIV continuum of care.
Academic Article The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.
Academic Article Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina.
Academic Article Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
Academic Article Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.
Academic Article Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
Academic Article A click chemistry amplified nanopore assay for ultrasensitive quantification of HIV-1 p24 antigen in clinical samples.
Search Criteria
  • HIV